Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Protagonist Therapeutics Inc buy Wolfe Research

Start price
€84.00
22.05.26 / 50%
Target price
-
22.05.27
Performance (%)
36.90%
Price
€115.00
03.08.26
Summary
This prediction is currently active. With a performance of 36.90% the BUY prediction by Wolfe_Research is a big success. This prediction currently runs until 22.05.27. The prediction end date can be changed by Wolfe_Research at any time. Wolfe_Research has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Protagonist Therapeutics Inc -0.833% -0.833%
iShares Core DAX® 2.591% 2.467%
iShares Nasdaq 100 -0.915% -6.458%
iShares Nikkei 225® 0.145% -8.773%
iShares S&P 500 -0.367% -1.220%

Comments by Wolfe_Research for this prediction

In the thread Protagonist Therapeutics Inc diskutieren

Protagonist Therapeutics (PTGX) was upgraded by Wolfe Research to "strong-buy".
Ratings data for PTGX provided by MarketBeat

Stopped prediction by Wolfe_Research for Protagonist Therapeutics Inc

buy
Protagonist Therapeutics Inc

Start price
Target price
Perf. (%)
€88.00
21.05.26
€116.17
21.05.27
30.68%
03.08.26